BioOhio Annual Conference 2011
June 16, 2011
October 27, 2011
Embassy Suites Dublin
Dublin, OH
Read More
June 16, 2011
BioOhio
BioEnterprise Corporation, Cleveland
BioStart
Edison Biotechnology Institute – Ohio University TechColumbus
Office of Governor John Kasich
Ohio Department of Health
Ohio House of Representatives
Ohio State Legislature
Ohio State Medical Association
Ohio State Senate
BioOhio – Government Relations Issues
June 16, 2011
BioOhio represents and advocates for Ohio’s bioscience community to improve business environment and public funding climate. Alone or in conjunction with partners and members, BioOhio pursues both a proactive and responsive advocacy program.
Read More
BioOhio – Government Relations Issues
June 16, 2011
BioOhio represents and advocates for Ohio’s bioscience community to improve business environment and public funding climate. Alone or in conjunction with partners and members, BioOhio pursues both a proactive and responsive advocacy program.
Read More
Ohio: #4 in overall biotechnology strength
June 16, 2011
In Business Facilities Magazine’s 2009 Biotechnology Strength Report released last fall, Ohio is once again ranked fourth among all states. California claimed top ranking, followed by Massachusetts, Pennsylvania, and Ohio. Maryland, Texas, New Jersey, Illinois, Kansas, and North Carolina rounded out the top 10.
Read More
14th Annual BIO CEO & Investor Conference
June 16, 2011
February 13-14, 2012
Waldorf Astoria
New York, NY
Read More
American Conference Institute – 2nd Annual Conference on Biosimilars
June 16, 2011
June 7-8, 2011
Millennium Plaza, United Nations
New York, NY
Read More
Central New York Biotechnology Symposium – 2011
June 16, 2011
June 3, 2011
Crowne Plaza Hotel
Syracuse, NY
Read More
New York Biotechnology Association Annual Meeting
June 16, 2011
April 6-7, 2011
New York Marriott Marquis
New York, NY
Read More
New York Biotechnology Association – 2011 Legislative Priorities
June 16, 2011
As the only statewide association in New York State dedicated solely to the issues of the bioscience industry, NYBA urges legislators to support the industry by focusing on issues that will create a better business climate that will allow companies at all stages of development to grow and succeed. NYBA is committed to policies that ensure patient access to the innovative therapies, devices and diagnostics that are being developed by the many bioscience companies across New York.
Read More
